Verta Patrick
Known title: EVP Clinical/Medical AffairsCIK: 0001586025
Associated companies
Transaction History
| NSPR | ▲ Buy | Grant | 83,072 | $0 | 1/7/2025 | View on chart |
| NSPR | ▲ Buy | Grant | 85,720 | $0 | 1/23/2024 | View on chart |
| NSPR | ▲ Buy | Grant | 83,072 | $0 | 1/7/2025 | View on chart |
| NSPR | ▲ Buy | Grant | 85,720 | $0 | 1/23/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
InspireMD (NSPR) noted in pre‑market health‑care stock moves
NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.
InspireMD (NSPR) noted in pre‑market health‑care stock moves. NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.